PubMed

Autoantibody response to islet transplantation in type 1 diabetes.

Bosi E, Braghi S, Maffi P, Scirpoli M, Bertuzzi F, Pozza G, Secchi A, Bonifacio E.

Diabetes. 2001 Nov;50(11):2464-71.PMID: 11679423 [PubMed - indexed for MEDLINE]Related articlesFree article

Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes.

Braghi S, Bonifacio E, Secchi A, Di Carlo V, Pozza G, Bosi E.

Diabetes. 2000 Feb;49(2):218-24.PMID: 10868938 [PubMed - indexed for MEDLINE]Related articlesFree article

Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.

Jaeger C, Hering BJ, Hatziagelaki E, Federlin K, Bretzel RG.

J Mol Med. 1999 Jan;77(1):45-8.PMID: 9930926 [PubMed - indexed for MEDLINE]Related articles

Islet cell antibodies and glutamic acid decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet-after-kidney transplantation.

Jaeger C, Hering BJ, Dyrberg T, Federlin K, Bretzel RG.

Transplantation. 1996 Aug 15;62(3):424-6.PMID: 8779696 [PubMed - indexed for MEDLINE]Related articles

Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts.

Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG.

Diabetes. 1997 Nov;46(11):1907-10.PMID: 9356046 [PubMed - indexed for MEDLINE]Related articles

Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression.

Brooks-Worrell BM, Peterson KP, Peterson CM, Palmer JP, Jovanovic L.

Transplantation. 2000 May 15;69(9):1824-9.PMID: 10830218 [PubMed - indexed for MEDLINE]Related articles

Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.

Keymeulen B, Ling Z, Gorus FK, Delvaux G, Bouwens L, Grupping A, Hendrieckx C, Pipeleers-Marichal M, Van Schravendijk C, Salmela K, Pipeleers DG.

Diabetologia. 1998 Apr;41(4):452-9.PMID: 9562350 [PubMed - indexed for MEDLINE]Related articles

Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression.

Brooks-Worrell BM, Peterson KP, Peterson CM, Palmer JP, Jovanovic L.

Transplantation. 2000 Jan 15;69(1):166-72.PMID: 10653397 [PubMed - indexed for MEDLINE]Related articles

IA-2 antibodies are only positive in association with GAD 65 and islet cell antibodies in islet transplanted insulin-dependent diabetes mellitus patients.

Jaeger C, Brendel MD, Hering BJ, Eckhard M, Federlin K, Bretzel RG.

Transplant Proc. 1998 Mar;30(2):659-60. No abstract available. PMID: 9532222 [PubMed - indexed for MEDLINE]Related articles

Kinetics of diabetes-associated autoantibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes.

Vantyghem MC, Fajardy I, Pigny P, Noel C, Kerr-Conte J, Gmyr V, Vandewalle B, Proye C, Pattou F.

Diabetes Metab. 2003 Dec;29(6):595-601.PMID: 14707888 [PubMed - indexed for MEDLINE]Related articlesFree article

Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients.

van Kampen CA, van de Linde P, Duinkerken G, van Schip JJ, Roelen DL, Keymeulen B, Pipeleers DG, Claas FH, Roep BO.

Transplantation. 2005 Jul 15;80(1):118-26.PMID: 16003242 [PubMed - indexed for MEDLINE]Related articles

Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.

Huurman VA, Hilbrands R, Pinkse GG, Gillard P, Duinkerken G, van de Linde P, van der Meer-Prins PM, Versteeg-van der Voort Maarschalk MF, Verbeeck K, Alizadeh BZ, Mathieu C, Gorus FK, Roelen DL, Claas FH, Keymeulen B, Pipeleers DG, Roep BO.

PLoS One. 2008 Jun 18;3(6):e2435.PMID: 18560516 [PubMed - indexed for MEDLINE]Related articlesFree article

Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation.

Bosi E, Bottazzo GF, Secchi A, Pozza G, Shattock M, Saunders A, Gelet A, Touraine JL, Traeger J, Dubernard JM.

Diabetes. 1989 Jan;38 Suppl 1:82-4.PMID: 2642861 [PubMed - indexed for MEDLINE]Related articles

Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.

Füchtenbusch M, Kredel K, Bonifacio E, Schnell O, Ziegler AG.

Diabetes. 2000 Jun;49(6):918-25.PMID: 10866043 [PubMed - indexed for MEDLINE]Related articlesFree article

Successful [correction of Succesful] transplantation of human islets in recipients bearing a kidney graft.

Bertuzzi F, Grohovaz F, Maffi P, Caumo A, Aldrighetti L, Nano R, Hengster P, Calori G, Di Carlo V, Bonifacio E, Secchi A.

Diabetologia. 2002 Jan;45(1):77-84.PMID: 11845226 [PubMed - indexed for MEDLINE]Related articles

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C.

Transplantation. 2002 Dec 27;74(12):1761-6.PMID: 12499894 [PubMed - indexed for MEDLINE]Related articles

[Islet transplantation in type I diabetes mellitus]

Lehmann R, Pavlicek V, Spinas GA, Weber M.

Ther Umsch. 2005 Jul;62(7):481-6. Review. German. PMID: 16075955 [PubMed - indexed for MEDLINE]Related articles

Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation.

Esmatjes E, Rodríguez-Villar C, Ricart MJ, Casamitjana R, Martorell J, Sabater L, Astudillo E, Fernández-Cruz L.

Transplantation. 1998 Jul 15;66(1):128-31.PMID: 9679835 [PubMed - indexed for MEDLINE]Related articles

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.

Hirshberg B, Rother KI, Digon BJ 3rd, Lee J, Gaglia JL, Hines K, Read EJ, Chang R, Wood BJ, Harlan DM.

Diabetes Care. 2003 Dec;26(12):3288-95.PMID: 14633816 [PubMed - indexed for MEDLINE]Related articlesFree article

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

Metabolism. 2003 Jan;52(1):25-9.PMID: 12524658 [PubMed - indexed for MEDLINE]Related articles